Inhalational Anthrax
·MeSH: Anthrax
Prevalence
0.1 / 100K
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(2)
Unknown(1)
| Drug | Company |
|---|---|
| aigiv | Emergent BioSolutions Inc. (EBS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Inhalational Anthrax?
BioSniper tracks 3 drugs in development for Inhalational Anthrax across 1 company.
How many clinical trials target Inhalational Anthrax?
There are 1 clinical trial targeting Inhalational Anthrax tracked by BioSniper.
What is the prevalence of Inhalational Anthrax?
The estimated prevalence of Inhalational Anthrax is approximately 0.1 per 100,000 population.
Deep-dive into Inhalational Anthrax
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis